Milrinone Lactate (Gland Pharma Limited)
Welcome to the PulseAid listing for the Milrinone Lactate drug offered from Gland Pharma Limited. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gland Pharma Limited |
NON-PROPRIETARY NAME: | Milrinone Lactate |
SUBSTANCE NAME: | MILRINONE LACTATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-07-28 |
END MARKETING DATE: | 0000-00-00 |
Milrinone Lactate HUMAN PRESCRIPTION DRUG Details:
Item Description | Milrinone Lactate from Gland Pharma Limited |
LABELER NAME: | Gland Pharma Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2017-07-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68083-318_43fd392a-531d-4d69-917e-f19b16272d7b |
PRODUCT NDC: | 68083-318 |
APPLICATION NUMBER: | ANDA077190 |
Other MILRINONE LACTATE Pharmaceutical Manufacturers / Labelers: